Benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate

Catalog No.: 
ACFAMZ250
CAS No.: 
414910-19-3
Molecular Formula: 
C19H16FNO3
Molecular Weight: 
325.34
Benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$206.00InquiryInquiry
250mg98%$373.00InquiryInquiry
1g98%$745.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate
IUPAC Namebenzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate
MDL No.MFCD11976091
Molecular FormulaC19H16FNO3
Molecular Weight325.34
SMILESO=C(N(C(C1=CC=C(F)C=C1)C2)C=CC2=O)OCC3=CC=CC=C3
InChI KeyPURXEFOXSLWNAW-UHFFFAOYSA-N
Synonym1(2H)-Pyridinecarboxylic acid, 2-(4-fluorophenyl)-3,4-dihydro-4-oxo-, phenylmethyl ester;Benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate
CAS No.414910-19-3

Synthetic Route by SureRoute

1. ACFAMZ250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDWYP408 route compound structure diagram
    ACDWYP408620-08-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFAMZ250 route product structure diagram
    ACFAMZ250414910-19-3
Inquiry

2. ACFAMZ250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFAMZ250 route product structure diagram
    ACFAMZ250414910-19-3
Inquiry

3. ACFAMZ250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFAMZ250 route product structure diagram
    ACFAMZ250414910-19-3
Inquiry

Comments (0)